Furthermore, survival analyses revealed that above median (MFI > 2327, N = 24) expression of NKp30 on CD56bright NK cells (P = 0.042) and above-median percentage ( > 20.3%, N = 24) of CD16+ NKT-like cells (P < 0.001) were associated with short DFS in CRC patients, with a HR of 2.143 (95% CI 1.009–4.551, P = 0.047) and 4.697 (95% CI 2.046–10.783, P < 0.001), respectively (Fig. 3b;3c). This evidence concerns the gene NCR3 and colorectal carcinoma.